Skip to main content
. 2017 Apr 1;56(7):773–779. doi: 10.2169/internalmedicine.56.7533

Table 1.

Description of the Study Population by Questionnaire.

Group All IGRA positive IGRA negative *p value
(QFT-GIT≥0.35 and/or T-SPOT≥6 spots) (other than positive)
n 654 33 (5.0%) 621 (95.0%)
symptom 16 (2.4%) 1 (3.0%) 15 (2.4%) NS
previous
abnormalities of chest 26 (4.0%) 11 (33.3%) 15 (2.4%) p<0.05
X-ray and/or IGRAs
history of TB treatment 16 (2.4%) 10 (30.3% 6 (1.0%) p<0.05
co-morbidity 17 (2.6%) 1 (3.0%) 16 (2.6%) NS
history of TB
exposure within 2 19 (2.9%) 1 (3.0%) 18 (2.9%) NS
years

Categorical variables were compared by the Pearson’s χ-squared test.

* p<0.05 was considered statistically significant. NS: not significant